List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 260 studies with search of:   "Pemetrexed"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Docetaxel or Pemetrexed With or Without Cetuximab in Patients With Recurrent or Progressive Non-Small Cell Lung Cancer
Condition: Non-Small-Cell Lung Cancer
Interventions: Drug: Docetaxel;   Drug: cetuximab and docetaxel;   Drug: Pemetrexed;   Drug: Cetuximab & Pemetrexed
2 Terminated Trial of Pemetrexed With or Without PF-3512676 in Advanced Non-Small Cell Lung Cancer
Condition: Carcinoma, Non-Small Cell Lung
Interventions: Drug: pemetrexed;   Drug: pemetrexed + PF-3512676
3 Recruiting A Safety Study Of Sunitinib In Combination With Pemetrexed In Patients With Advanced Solid Malignancies
Condition: Neoplasms
Interventions: Drug: Sunitinib, Pemetrexed;   Drug: Sunitinib, Pemetrexed
4 Recruiting A Study of Pemetrexed, Carboplatin and Bevacizumab in Patients With Nonsquamous Non-Small Cell Lung Cancer
Condition: Non-Small Cell Lung Cancer
Interventions: Drug: Pemetrexed;   Drug: Pemetrexed;   Drug: Paclitaxel;   Drug: Carboplatin;   Biological: Bevacizumab;   Biological: Bevacizumab
5 Recruiting Pemetrexed Plus Gemcitabine in Renal Cell Cancer
Condition: Renal Cell Carcinoma
Interventions: Drug: Pemetrexed;   Drug: Gemcitabine
6 Recruiting Study of CBP501 + Pemetrexed + Cisplatin in Patients With Solid Tumors (Phase I) and Patients With Malignant Pleural Mesothelioma (Phase II)
Conditions: Malignant Pleural Mesothelioma;   MPM;   Solid Tumors
Interventions: Drug: pemetrexed, cisplatin and CBP501;   Drug: pemetrexed and cisplatin
7 Active, not recruiting Effects of Matuzumab in Combination With Pemetrexed for the Treatment of Advanced Lung Cancer
Conditions: Lung Cancer;   Non Small Cell Lung Carcinoma
Interventions: Drug: Pemetrexed;   Drug: Matuzumab + Pemetrexed;   Drug: Matuzumab + Pemetrexed
8 Recruiting Pemetrexed +/- Carboplatin as Second Line Treatment in NSCLC
Condition: Advanced Non-Small Cell Lung Cancer
Interventions: Drug: Pemetrexed;   Drug: Pemetrexed plus carboplatin
9 Recruiting Carboplatin, Bevacizumab and Pemetrexed in the First-Line Treatment of Patients With MPM
Condition: Mesothelioma
Intervention: Drug: Carboplatin, Bevacizumab and Pemetrexed
10 Active, not recruiting Pemetrexed (Alimta) in Patients With Head and Neck Squamous Cell Cancer
Condition: Head and Neck Cancer
Interventions: Drug: Pemetrexed;   Drug: Dexamethasone
11 Recruiting A Study of Induction and Maintenance Treatment of Advanced Non-Squamous Non Small Cell Lung Cancer
Condition: Non-Small Cell Lung Cancer
Interventions: Drug: Pemetrexed;   Drug: Cisplatin;   Drug: Placebo;   Drug: Pemetrexed;   Other: Best Supportive Care
12 Recruiting Cisplatin, Pemetrexed, and Imatinib Mesylate in Malignant Mesothelioma
Condition: Mesothelioma
Interventions: Drug: Cisplatin;   Drug: Imatinib Mesylate;   Drug: Pemetrexed
13 Recruiting Trial of Pemetrexed Versus Erlotinib in Pretreated Patients With Non Small Cell Lung Cancer (NSCLC)
Condition: Non Small Cell Lung Cancer
Interventions: Drug: Erlotinib (Tarceva);   Drug: Pemetrexed (Alimta)
14 Recruiting A Study To Find The Best Dose Of SU011248 When Given With Pemetrexed, Pemetrexed And Cisplatin Or Pemetrexed And Carboplatin In Patients With Advanced Solid Tumors
Conditions: Mesothelioma;   Non-Small Cell Lung Cancer;   Neoplasms
Intervention: Drug: Sunitinib, Pemetrexed, Cisplatin, Carboplatin
15 Active, not recruiting A Phase II Study of Pemetrexed Plus Gemcitabine for Metastatic/Recurrent Head and Neck Cancer (HNSCC)
Condition: Head and Neck Cancer
Intervention: Drug: Pemetrexed plus Gemcitabine
16 Recruiting A Study of Pemetrexed Plus Carboplatin, or Pemetrexed Plus Cisplatin With Radiation Therapy Followed by Pemetrexed in Patients With Inoperable Non-Small-Cell Lung Cancer
Condition: Non-Small-Cell Lung Cancer
Interventions: Drug: pemetrexed;   Drug: cisplatin;   Drug: carboplatin;   Radiation: radiation therapy
17 Active, not recruiting Efficacy Study Comparing ZD6474 in Combination With Pemetrexed and Pemetrexed Alone in 2nd Line NSCLC Patients
Conditions: Non Small Cell Lung Cancer;   Lung Cancer
Interventions: Drug: Vandetanib;   Drug: Pemetrexed
18 Recruiting Evaluation of of Multimodality Treatment Pemetrexed Combined With Cisplatin and Radiotherapy for Unresectable Locally Advanced NSCLC
Condition: Non-Small Cell Lung Cancer
Interventions: Drug: cisplatin/pemetrexed;   Procedure: pemetrexed/radiation therapy
19 Recruiting A Phase II Study of Pemetrexed and Carboplatin in the Treatment of Esophageal Cancer
Condition: Esophageal Neoplasms
Interventions: Drug: pemetrexed;   Drug: carboplatin
20 Active, not recruiting A Phase 2 Study Evaluating ABT-751 in Combination With Alimta in Advanced Non-Small Cell Lung Cancer
Conditions: Non-Small-Cell Lung Cancer;   Lung Cancer;   NSCLC
Interventions: Drug: ABT-751;   Drug: pemetrexed;   Drug: placebo

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services